Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
3
×
life sciences
national blog main
national top stories
biotech
boston
new york blog main
new york top stories
third rock ventures
ally bridge group
antisense oligonucleotide
benzodiazepines
big data analytics
biogen
blackrock
blackstone group
blackstone life sciences
blueprint medicines
boulder/denver blog main
boulder/denver top stories
cancer
casdin capital
columbia university
companion diagnostic
david goldstein
depression
detroit blog main
detroit top stories
diabetic nephropathy
dna sequencing
drugs
entrectinib
epi4k
epilepsy
essential tremor
eventide asset management
express scripts
fda
What
genetic
3
×
new
3
×
drug
medicines
aims
analysis
approved
backed
bio
biotech
bring
cancer
cause
ceo
company
deeper
develop
diseases
dna
drugs
employing
epilepsy
fda
fingerprint
genes
going
goldfinch
ipo
kidney
later
lead
links
marcio
matter
medicine
million
mutations
nd
neuro
oks
Language
unset
Current search:
genetic
×
new
×
" clinical trials "
×
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
